Use of JC virus antibody index to stratify risk of progressive multifocal leukoencephalopathy in natalizumab-treated patients with multiple sclerosis

被引：0
|
作者：
Plavina, T. [1 ]
Subramanyam, M. [1 ]
Bloomgren, G. [1 ]
Richman, S. [1 ]
Pace, A. [1 ]
Lee, S. [1 ]
Schlain, B. [1 ]
Campagnolo, D. [1 ]
Ticho, B. [1 ]
机构：
[1] Biogen Idec Inc, Weston, MA USA
来源：
JOURNAL OF NEUROLOGY | 2013年 / 260卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
O228
引用
收藏
页码：S13 / S13
页数：1
相关论文
共 50 条
  • [31] More on JC Viremia in Natalizumab-Treated Patients with Multiple Sclerosis
    Subramanyam, Meena
    Belachew, Shibeshih
    Compton, Teresa
    NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (13): : 1279 - 1280
  • [32] Progressive multifocal leukoencephalopathy in two natalizumab-treated stepsisters: An intriguing coincidence
    Bacchetta, Frederic
    Mathias, Amandine
    Schluep, Myriam
    Du Pasquier, Renaud
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 (02) : 300 - 303
  • [33] Risk stratification for progressive multifocal leukoencephalopathy in patients treated with natalizumab
    Sorensen, Per Soelberg
    Bertolotto, Antonio
    Edan, Gilles
    Giovannoni, Gavin
    Gold, Ralf
    Havrdova, Eva
    Kappos, Ludwig
    Kieseier, Bernd C.
    Montalban, Xavier
    Olsson, Tomas
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 (02) : 143 - 152
  • [34] Is the risk of progressive multifocal leukoencephalopathy the real reason for natalizumab discontinuation in patients with multiple sclerosis?
    Kraemer, Julia
    Tenberge, Jan-Gerd
    Kleiter, Ingo
    Gaissmaier, Wolfgang
    Ruck, Tobias
    Heesen, Christoph
    Meuth, Sven G.
    PLOS ONE, 2017, 12 (04):
  • [35] Is the risk of progressive multifocal leukoencephalopathy the real reason for natalizumab discontinuation in patients with multiple sclerosis?
    Kraemer, J.
    Tenberge, J. -G.
    Kleiter, I.
    Gaissmaier, W.
    Ruck, T.
    Heesen, C.
    Meuth, S. G.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 380 - 381
  • [36] Progressive Multifocal Leukoencephalopathy with Natalizumab Treatment of Multiple Sclerosis
    Clifford, David B.
    DeLuca, Andrea
    Simpson, David
    Arendt, Gabriele
    Giovannoni, Gavin
    Nath, Avindra
    NEUROLOGY, 2010, 74 (09) : A281 - A282
  • [37] Progressive multifocal leukoencephalopathy, natalizumab, and multiple sclerosis - Reply
    Kleinschmidt-DeMasters, BK
    Tyler, KL
    NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (16): : 1745 - 1745
  • [38] Multiple sclerosis, natalizumab therapy, and progressive multifocal leukoencephalopathy
    Bartt, Russell E.
    CURRENT OPINION IN NEUROLOGY, 2006, 19 (04) : 341 - 349
  • [39] JC and BK virus in natalizumab-treated patients
    Barrett, Kathleen V.
    Puccio, Lauren M.
    Brydon, Edward W.
    Sadiq, Saud A.
    MULTIPLE SCLEROSIS, 2008, 14 : S176 - S177
  • [40] More on JC Viremia in Natalizumab-Treated Patients with Multiple Sclerosis REPLY
    Major, Eugene O.
    Frohman, Elliot
    Douek, Daniel
    NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (13): : 1280 - 1280
12345